S. Thaddeus Connelly

DDS, MD, PhD, FACS. UCSF Clinical Professor and Residency Program Director,

Oral and Maxillofacial Surgery. Staff Surgeon, San Francisco VA Medical Center.

Founder and CEO, Gengyve USA. Disabled veteran.

Nine parallel domains. 60+ publications. R01 Principal Investigator. 18+ years

as residency program director. The person who named and defined the

Oral-Vascular-Neural Nexus.

Scientific Identity

Oral and maxillofacial surgeon turned systems thinker. My research program

asks a single question: how do bacterial extracellular vesicles from the

periodontal pocket drive systemic disease? The answer is the

OVN Nexus — a network medicine framework that maps the

oral cavity as an upstream source node for cardiovascular, neurological,

and oncological pathology via a conserved bEV cascade.

I didn't discover that periodontal disease correlates with systemic disease.

Hundreds of studies established that. I specified the mechanism — vesicle-

mediated transport of pathological information from subgingival biofilm

to distal tissues — and built the framework that makes it falsifiable,

measurable, and protocol-generating.

The scientific thesis lives at ovnnexus.com and

is narrated in real time at the

Quantum Distillery Substack.

Key Contributions

Proposed the OVN Nexus as the organizing thesis for oral-systemic medicine
Defined the bEV Cascade: five-step conserved

pathological program

Developed the Biomineralization Hypothesis:

bEV-mediated pathological calcification

Applied network medicine to oral-

systemic pathology (mouth as upstream source node)

Introduced IT-from-Qubit framing of bEV-mediated

information transfer

Created Terminal Event Pedagogy: retrograde

teaching method for oral-systemic education

60+ peer-reviewed publications in oral-systemic pathology, surgical

technique, and complexity science

Academic Positions

Clinical Professor, UCSF Department of Oral and Maxillofacial Surgery
Residency Program Director, UCSF OMS (18+ years)
Staff Surgeon, San Francisco VA Medical Center
R01 Principal Investigator

Collaborators

Alessandra Lanzara (UC Berkeley) — pump-probe spectroscopy, quantum biology
A. Mata — biomaterials, tissue engineering
Anant Madabhushi — computational pathology, imaging AI

Marketing Identity

As B2B/DSO Founder

Surgeon-scientist who built the science, then built the company. Gengyve

isn't a dental startup with a pitch deck — it's the commercialization of

a 20-year research program by the person who defined the field. I've

operated on over 10,000 patients, directed a surgical residency for nearly

two decades, and published the science that oral-systemic is built on.

When I tell a DSO that oral-systemic integration is an operational

advantage, I'm not selling a theory — I'm deploying a body of work that

includes 60+ publications, an R01, and a clinical protocol system tested

at UCSF and the VA. Disabled veteran founder. Nine parallel domains.

The science is mine. The protocol is mine. The company exists to

operationalize both at scale.

As Clinical Category Definer

I'm the colleague who's been in the OR and the lab for the same problem

you're starting to notice in your hygiene operatory. The connection

between periodontal disease and systemic disease isn't new — the

mechanism is. Bacterial extracellular vesicles. A conserved five-step

cascade. Measurable at every step. I defined the OVN Nexus,

built the Fasolati Triad protocol architecture,

and designed the certification pathway (Sentinel → Navigator → Integrator →

Architect) that gives hygienists and periodontists a professional identity

in oral-systemic medicine. The ADA CERP CE modules teach the mechanism

using Terminal Event Pedagogy — start

with the heart attack, work backward to the pocket. I'm not selling you

CE credits. I'm giving you the framework your practice needs for the

next decade.

As Scientific Thought Leader

The oral-systemic space has been stuck in the correlation phase for

thirty years. Hundreds of epidemiological studies showing associations.

Zero mechanistic frameworks generating falsifiable predictions. I built

that framework. The OVN Nexus specifies the transport

mechanism (bacterial extracellular vesicles), the effector program

(innate immune activation via conserved pattern recognition), and the

network topology (multi-pathogen, multi-organ, convergent pathology via

bEV-seeded interactome perturbation). It borrows from Barabási's network

medicine, Wheeler's information-theoretic physics, and complexity science's

understanding of conserved programs across scales. The Quantum Distillery

is where I narrate this work in real time — not as finished science but as

the honest middle between campfire and ivory tower.

If you're a researcher, cite the framework. If you're a KOL, engage the

thesis. If you're a VC, this is the category before the market prices it in.